Abstract
Stem cells of various origins have shown enormous potential to enhance bone repair and regeneration. From fracture healing to bone loss, including well-known medical conditions like osteoporosis, stem cells are being applied more and more frequently. Furthermore, they are being proposed for the treatment of genetic bone disorders with satisfactory outcomes. However, key questions remain on the type of cell to use, and the isolation and expansion protocols to select. Moreover, the in vitro modification of the cells to induce a specific phenotype, enabling regeneration of new bone is being matter of extensive research. In that respect, a possibility also exists for the enhancement of vascularization during bone regeneration events by using coculture systems or endothelial-based cell therapies. It is our intention in this chapter, to bring to the reader an update on the use of stem cells to treat bone disorders. In light of that, important concepts and definitions will be presented, as well as some examples of relevant findings. Finally, clinical trials on this topic will be discussed.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fröhlich M, Grayson WL, Wan LQ, Marolt D, Drobnic M, Vunjak-Novakovic G (2008) Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther 3:254–264
Clines GA (2010) Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis. Curr Opin Organ Transplant 15:73–78
Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332–336
Robey PG, Boskey AL (2008) The composition of bone. In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, DC, pp 32–38
Marks SC, Odgren PR (2002) Structure and development of the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology. Academic, London, pp 3–15
Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W (2002) The bone lining cell: its role in cleaning Howship’s lacunae and initiating bone formation. J Bone Miner Res 17:77–90
Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392–1404
Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355:S7–S21
Tanner KE (2010) Bioactive ceramic-reinforced composites for bone augmentation. J R Soc Interf 5:541–557
Tanner KE (2010) Bioactive composites for bone tissue engineering. Proc Inst Mech Eng H 224:1359–1372
Brydone AS, Meek D, Maclaine S (2010) Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng H 224:1329–1343
Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D (2010) Orthopaedic applications of bone graft & graft substitutes: a review. Indian J Med Res 132:15–30
Zaidi N, Nixon AJ (2007) Stem cell therapy in bone repair and regeneration. Ann N Y Acad Sci 1117:62–72
Shapiro F (2008) Bone development and its relation to fracture repair: the role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15:53–76
Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP (2008) Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 214:537–544
Gerber HP, Ferrara N (2000) Angiogenesis and bone growth. Trends Cardiovasc Med 10:223–228
Santos MI, Reis RL (2010) Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10:12–27
Chung UI, Kawaguchi H, Takato T, Nakamura K (2004) Distinct osteogenic mechanisms of bones of distinct origins. J Orthop Sci 9:410–414
Schmid J, Wallkamm B, Hämmerle CH, Gogolewski S, Lang NP (1997) The significance of angiogenesis in guided bone regeneration: a case report of a rabbit experiment. Clin Oral Implants Res 8:244–248
Tarkka T, Sipola A, Jämsä T, Soini Y, Ylä-Herttuala S, Tuukkanen J, Hautala T (2003) Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5:560–566
Chen RR, Silva EA, Yuen WW, Mooney DJ (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24:258–264
Zisch AH, Lutolf MP, Hubbell JA (2003) Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12:295–310
Grellier M, Bordenave L, Amédée J (2009) Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27:562–571
Schumann P, Tavassol F, Lindhorst D, Stuehmer C, Bormann K-H, Kampmann A, Mülhaupt R, Laschke MW, Menger MD, Gellrich N-C, Rücker M (2009) Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. Microvasc Res 78:180–190
Singh S, Wu BM, Dunn JCY (2011) Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells. Tissue Eng 17:1819–1830
Erbs S, Linke A, Schachinger V, Assmus B, Thiele H, Diederich KW, Hoffmann C, Dimmeler S, Tonn T, Hambrecht R, Zeiher AM, Schuler G (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116:366–374
Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416–1423
Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937
Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, Testa L, Livigni S, Fagioli F (2006) Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 28:523–526
Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390–1397
Friedenstein AJ, Chailakhyan RK, Gerasimov UV (1987) Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263–272
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192
Mosna F, Sensebé L, Krampera M (2010) Human bone marrow and adipose tissue mesenchymal stem cells: a user’s guide. Stem Cells Dev 19:1449–1470
Lennon DP, Caplan AI (2006) Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol 34:1604–1605
Barrilleaux B, Phinney DG, Prockop DJ, O‘Connor KC (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12:3007–3019
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Schliephake H, Zghoul N, Jager V, van Griensven M, Zeichen J, Gelinsky M, Szubtarsky N (2009) Bone formation in trabecular bone cell seeded scaffolds used for reconstruction of the rat mandible. Int J Oral Maxillofac Surg 38:166–172
Forraz N, McGuckin CP (2011) The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif 44(Suppl 1):60–69
Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A (2010) Alternative sources of adult stem cells: human amniotic membrane. Adv Biochem Eng Biotechnol 123:1–27
Balmayor ER, Feichtinger GA, Azevedo HS, van Griensven M, Reis RL (2009) Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2. Clin Orthop Relat Res 467:3138–3148
Keibl C, Fuegl A, Zanoni G, Tangl S, Wolbank S, Redl H, van Griensven M (2011) Human adipose derived stem cells reduce callus volume upon BMP-2 administration in bone regeneration. Injury 42:814–820
Shen HC, Peng H, Usas A, Gearhart B, Fu FH, Huard J (2004) Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 6:984–991
Meinel L, Hofmann S, Betz O, Fajardo R, Merkle HP, Langer R, Evans CH, Vunjak-Novakovic G, Kaplan DL (2006) Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 27:4993–5002
Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035–3039
Wall ME, Bernacki SH, Loboa EG (2007) Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng 13:1291–1298
Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23:1357–1366
Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385–386
Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J (2001) Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 344:1511–1514
Hentz VR, Chang J (2001) Tissue engineering for reconstruction of the thumb. N Engl J Med 344:1547–1548
Schimming R, Schmelzeisen R (2004) Tissue-engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 62:724–729
Schmelzeisen R, Schimming R, Sittinger M (2003) Making bone: implant insertion into tissue-engineered bone for maxillary sinus floor augmentation-a preliminary report. J Craniomaxillofac Surg 31:34–39
Ueda M, Yamada Y, Ozawa R, Okazaki Y (2005) Clinical case reports of injectable tissue engineered bone for alveolar augmentation with simultaneous implant placement. Int J Periodontics Restorat Dent 25:129–137
Kasow K (2008) Treatment of severe osteogenesis imperfecta by allogeneic bone marrow transplantation. St. Jude Children’s Research Hospital. www.clinicaltrials.gov, NCT00705120
Kasow K (2011) Stem cell transplantation for children affected with osteopetrosis. St. Jude Children’s Research Hospital. www.clinicaltrials.gov, NCT00145587
Orchard P (2011) Reduced intensity allotransplant for osteopetrosis. Masonic Cancer Center, University of Minnesota. www.clinicaltrials.gov, NCT00638820
Orchard P (2011) Allogeneic transplantation for severe osteopetrosis. Masonic Cancer Center, University of Minnesota. www.clinicaltrials.gov, NCT00775931
Hamidieh AA (2011) Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis. Tehran University of Medical Sciences. www.clinicaltrials.gov, NCT01087398
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Balmayor, E.R., van Griensven, M. (2013). Stem Cell Therapy for Bone Disorders. In: Chase, L., Vemuri, M. (eds) Mesenchymal Stem Cell Therapy. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-200-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-62703-200-1_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-199-8
Online ISBN: 978-1-62703-200-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)